APA (7th ed.) Citation

Zak, J., Pratumchai, I., Marro, B. S., Marquardt, K. L., Oldstone, M. B., Varner, J. A., . . . Teijaro, J. R. (2023). 846 Myeloid reprogramming by JAK inhibition enhances checkpoint blockade immunotherapy. Journal for immunotherapy of cancer, 11(Suppl 1), A944. https://doi.org/10.1136/jitc-2023-SITC2023.0846

Chicago Style (17th ed.) Citation

Zak, Jaroslav, Isaraphorn Pratumchai, Brett S. Marro, Kristi L. Marquardt, Michael BA Oldstone, Judith A. Varner, Veronika Bachanova, and John R. Teijaro. "846 Myeloid Reprogramming by JAK Inhibition Enhances Checkpoint Blockade Immunotherapy." Journal for Immunotherapy of Cancer 11, no. Suppl 1 (2023): A944. https://doi.org/10.1136/jitc-2023-SITC2023.0846.

MLA (9th ed.) Citation

Zak, Jaroslav, et al. "846 Myeloid Reprogramming by JAK Inhibition Enhances Checkpoint Blockade Immunotherapy." Journal for Immunotherapy of Cancer, vol. 11, no. Suppl 1, 2023, p. A944, https://doi.org/10.1136/jitc-2023-SITC2023.0846.